An anti-CRISPR viral ring nuclease subverts type III CRISPR immunity. (2020)
Attributed to:
Cyclic oligoadenylate signalling - a new type of antiviral response
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41586-019-1909-5
PubMed Identifier: 31942067
Publication URI: http://europepmc.org/abstract/MED/31942067
Type: Journal Article/Review
Volume: 577
Parent Publication: Nature
Issue: 7791
ISSN: 0028-0836